NCT00329004View on ClinicalTrials.gov

A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
CancerTumor
Interventions
DRUG

BMS-690514

Tablets, Oral, up to 300 mg, once daily, up to 24 mos

Trial Locations (7)

31052

Local Institution, Toulouse

46202

Indiana University Med Center, Indianapolis

77030

The University Of Texas Md Anderson Cancer Center, Houston

94805

Local Institution, Villejuif

K1H 8L6

Local Institution, Ottawa

M5G 2M9

Local Institution, Toronto

08035

Local Institution, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY